Immersive virtual reality with synchronous neurostimulation for upper-limb recovery after stroke: a randomized feasibility trial

Nature Medicine, Published online: 26 June 2026; doi:10.1038/s41591-026-04486-4

A multimodal platform combining immersive virtual reality with a synchronous sensory neurostimulation protocol outperformed conventional rehabilitation in individuals with chronic stroke, driving upper-limb motor gains, restored body representation and improved tactile acuity while enabling objective kinematic tracking of recovery.

Cliramitug for depletion of cardiac amyloid transthyretin: long-term follow-up of the NI006-101 trial

Nature Medicine, Published online: 26 June 2026; doi:10.1038/s41591-026-04487-3

In an open-label extension study of the NI006-101 trial, in which patients with transthyretin amyloidosis cardiomyopathy were treated with the monoclonal antibody cliramitug, which targets misfolded transthyretin, long-term follow-up for a median of 29.3 months showed favorable safety, further reduction in cardiac amyloid burden and improvements in structural, functional and biomarker endpoints.

Mitochondrial stress response drives microglial senescence

Nature Neuroscience, Published online: 26 June 2026; doi:10.1038/s41593-026-02264-6

The mitochondrial unfolded protein response (UPRmt) drives microglial senescence and disrupts essential glia–neuron communication. By triggering lipid droplet accumulation and dysregulating the S-adenosylmethionine–polyamine axis, UPRmt fuels the senescence-associated secretory pathway, impairs synaptic pruning and accelerates misfolded protein pathology. In this issue of Nature Neuroscience, Perez et al. identify UPRmt as a primary driver of metabolic vulnerability in human microglia.

Conditioned accumbal dopamine transients forecast individual preference for drug versus natural rewards and compulsive behavior

Nature Neuroscience, Published online: 26 June 2026; doi:10.1038/s41593-026-02331-y

Pascoli et al. show that nucleus accumbens dopamine transients evoked by reward-predictive cues encode subjective reward value in mice, predicting individual preference for drugs over natural rewards and forecasting vulnerability to compulsive drug-seeking behavior.